Tapewire

Nasdaq · USD

CYTK

CYTOKINETICS INC

Export transactions ↓
Tapewire entity
3528
SEC CIK
0001061983
Parsed reports
875

Last 12 months

Inside the activity.

0 purchase rows · 83 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202509
Jan 202603
Feb 202602
Mar 2026017
Apr 202608
May 202609
Jun 202608
Jul 202609
Aug 202604
Sep 202608
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 14, 2024 Filed Mar 18, 2024 22:52 UTC
Blum Robert IDirector · President & CEO
GrantIncentive Stock Option (Right to Buy) · Derivative 1,568 $0.00 Strike: $63.75 $0.00
Disclosure

SEC source: 0001127602-24-010515 · form4.xml · derivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,568

Underlying: Common Stock · 1,568 shares

Expires 2034-03-14

F4 · kind: Award comprised of Non Statutory Stock Options that will vest and become exercisable over 4 years in monthly installments starting April 15, 2024, with the final monthly installment vesting on March 14, 2028.

Read SEC document
March 14, 2024 Filed Mar 18, 2024 22:52 UTC
Blum Robert IDirector · President & CEO
GrantCommon Stock 61,490 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-010515 · form4.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 461,221

F1 · kind: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an addiitional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:26 UTC
Wong RobertVP, Chief Accounting Officer
Tax withholdingCommon Stock 857 $66.88 $57,316.16
Disclosure

SEC source: 0001127602-24-009017 · form4.xml · nonDerivative · entry 2

Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,585

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:24 UTC
Malik Fady IbrahamEVP Research & Development
Tax withholdingCommon Stock 8,109 $66.88 $542,329.92
Disclosure

SEC source: 0001127602-24-009016 · form4.xml · nonDerivative · entry 2

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,234

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:22 UTC
Blum Robert IDirector · President & CEO
Tax withholdingCommon Stock 16,725 $66.88 $1,118,568.00
Disclosure

SEC source: 0001127602-24-009013 · form4.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 399,731

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:18 UTC
Callos AndrewEVP, Chief Commercial Officer
Tax withholdingCommon Stock 5,103 $66.88 $341,288.64
Disclosure

SEC source: 0001127602-24-009010 · form4.xml · nonDerivative · entry 2

Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,946

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person.

Read SEC document
March 05, 2024 Filed Mar 5, 2024 21:05 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 28,604 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-24-008501 · form4.xml · derivative · entry 4

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,605

Underlying: Common Stock · 28,604 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
March 05, 2024 Filed Mar 5, 2024 21:05 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 28,604 $67.56 $1,932,486.24
Disclosure

SEC source: 0001127602-24-008501 · form4.xml · nonDerivative · entry 3

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,973

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
March 05, 2024 Filed Mar 5, 2024 21:05 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionCommon Stock 28,604 $6.67 $190,788.68
Disclosure

SEC source: 0001127602-24-008501 · form4.xml · nonDerivative · entry 2

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 167,577

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
March 05, 2024 Filed Mar 5, 2024 21:05 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 4,000 $67.53 $270,120.00
Disclosure

SEC source: 0001127602-24-008501 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,973

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
March 04, 2024 Filed Mar 7, 2024 21:26 UTC
Wong RobertVP, Chief Accounting Officer
Tax withholdingCommon Stock 1,783 $67.68 $120,673.44
Disclosure

SEC source: 0001127602-24-009017 · form4.xml · nonDerivative · entry 1

Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,442

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person.

Read SEC document
March 04, 2024 Filed Mar 7, 2024 21:24 UTC
Malik Fady IbrahamEVP Research & Development
Tax withholdingCommon Stock 9,630 $67.68 $651,758.40
Disclosure

SEC source: 0001127602-24-009016 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,343

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person.

Read SEC document
March 04, 2024 Filed Mar 7, 2024 21:22 UTC
Blum Robert IDirector · President & CEO
Tax withholdingCommon Stock 25,341 $67.68 $1,715,078.88
Disclosure

SEC source: 0001127602-24-009013 · form4.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 416,456

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person.

Read SEC document
March 04, 2024 Filed Mar 7, 2024 21:18 UTC
Callos AndrewEVP, Chief Commercial Officer
Tax withholdingCommon Stock 2,202 $67.68 $149,031.36
Disclosure

SEC source: 0001127602-24-009010 · form4.xml · nonDerivative · entry 1

Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,049

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person.

Read SEC document
February 14, 2024 Filed Feb 14, 2024 21:04 UTC Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $4.44 $0.00
Disclosure

SEC source: 0001127602-24-004994 · form4.xml · derivative · entry 4

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2024-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.

Read SEC document
February 14, 2024 Filed Feb 14, 2024 21:04 UTC SaleCommon Stock 5,000 $76.48 $382,400.00
Disclosure

SEC source: 0001127602-24-004994 · form4.xml · nonDerivative · entry 3

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,632

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.

Read SEC document
February 14, 2024 Filed Feb 14, 2024 21:04 UTC Exercise / conversionCommon Stock 5,000 $4.44 $22,200.00
Disclosure

SEC source: 0001127602-24-004994 · form4.xml · nonDerivative · entry 2

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,632

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.

Read SEC document
February 13, 2024 Filed Feb 13, 2024 21:01 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-24-004668 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,494

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
February 13, 2024 Filed Feb 13, 2024 21:01 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $76.85 $960,625.00
Disclosure

SEC source: 0001127602-24-004668 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,797

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
February 13, 2024 Filed Feb 13, 2024 21:01 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-24-004668 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 454,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
February 06, 2024 Filed Feb 6, 2024 21:43 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 28,605 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-24-003582 · form4.xml · derivative · entry 4

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,209

Underlying: Common Stock · 28,605 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
February 06, 2024 Filed Feb 6, 2024 21:43 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 4,000 $79.28 $317,120.00
Disclosure

SEC source: 0001127602-24-003582 · form4.xml · nonDerivative · entry 3

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,973

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
February 06, 2024 Filed Feb 6, 2024 21:43 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 28,605 $79.30 $2,268,376.50
Disclosure

SEC source: 0001127602-24-003582 · form4.xml · nonDerivative · entry 2

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 146,973

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
February 06, 2024 Filed Feb 6, 2024 21:43 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionCommon Stock 28,605 $6.67 $190,795.35
Disclosure

SEC source: 0001127602-24-003582 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,578

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:41 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-24-003154 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,994

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:41 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $79.57 $994,625.00
Disclosure

SEC source: 0001127602-24-003154 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,797

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:41 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-24-003154 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 454,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
January 19, 2024 Filed Jan 22, 2024 22:19 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-24-001841 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 143,494

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
January 19, 2024 Filed Jan 22, 2024 22:19 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $81.42 $1,017,750.00
Disclosure

SEC source: 0001127602-24-001841 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,797

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
January 19, 2024 Filed Jan 22, 2024 22:19 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-24-001841 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 454,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
January 12, 2024 Filed Jan 12, 2024 22:20 UTC Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $4.44 $0.00
Disclosure

SEC source: 0001127602-24-001286 · form4.xml · derivative · entry 4

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2024-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.

Read SEC document
January 12, 2024 Filed Jan 12, 2024 22:20 UTC SaleCommon Stock 5,000 $85.14 $425,700.00
Disclosure

SEC source: 0001127602-24-001286 · form4.xml · nonDerivative · entry 3

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,632

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.

Read SEC document
January 12, 2024 Filed Jan 12, 2024 22:20 UTC Exercise / conversionCommon Stock 5,000 $4.44 $22,200.00
Disclosure

SEC source: 0001127602-24-001286 · form4.xml · nonDerivative · entry 2

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,632

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.

Read SEC document
January 04, 2024 Filed Jan 4, 2024 21:36 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative 11,678 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001127602-24-000835 · form4.xml · derivative · entry 4

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,678 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
January 04, 2024 Filed Jan 4, 2024 21:36 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 4,000 $86.99 $347,960.00
Disclosure

SEC source: 0001127602-24-000835 · form4.xml · nonDerivative · entry 3

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 146,973

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
January 04, 2024 Filed Jan 4, 2024 21:36 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 11,678 $86.98 $1,015,752.44
Disclosure

SEC source: 0001127602-24-000835 · form4.xml · nonDerivative · entry 2

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,973

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
January 04, 2024 Filed Jan 4, 2024 21:36 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionCommon Stock 11,678 $7.96 $92,956.88
Disclosure

SEC source: 0001127602-24-000835 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 162,651

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.

Read SEC document
January 02, 2024 Filed Jan 2, 2024 22:55 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $6.67 $0.00
Disclosure

SEC source: 0001127602-24-000165 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 155,994

Underlying: Common Stock · 12,500 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
January 02, 2024 Filed Jan 2, 2024 22:55 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $85.08 $1,063,500.00
Disclosure

SEC source: 0001127602-24-000165 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,797

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
January 02, 2024 Filed Jan 2, 2024 22:55 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $6.67 $83,375.00
Disclosure

SEC source: 0001127602-24-000165 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 454,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 21:29 UTC GrantCommon Stock 74 $84.12 $6,224.88
Disclosure

SEC source: 0001127602-24-000441 · form4.xml · nonDerivative · entry 1

Wysenski Nancy · CIK 0001294596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,156

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $84.12, representing the Issuer's closing stock price on January 2, 2024.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 21:27 UTC GrantCommon Stock 74 $84.12 $6,224.88
Disclosure

SEC source: 0001127602-24-000433 · form4.xml · nonDerivative · entry 1

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,727

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $84.12, representing the Issuer's closing stock price on January 2, 2024.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 21:25 UTC GrantCommon Stock 148 $84.12 $12,449.76
Disclosure

SEC source: 0001127602-24-000429 · form4.xml · nonDerivative · entry 1

SMITH SANDFORD D · CIK 0001243004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,801

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $84.12, representing the Issuer's closing stock price on January 2, 2024.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 21:23 UTC GrantCommon Stock 148 $84.12 $12,449.76
Disclosure

SEC source: 0001127602-24-000426 · form4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,317

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $84.12, representing the closing stock price of the Issuer's common stock on January 2, 2024.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 21:21 UTC GrantCommon Stock 252 $84.12 $21,198.24
Disclosure

SEC source: 0001127602-24-000425 · form4.xml · nonDerivative · entry 1

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,632

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $84.12, representing the closing stock price of the Issuer's common stock on January 2, 2024.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 21:20 UTC GrantCommon Stock 148 $84.12 $12,449.76
Disclosure

SEC source: 0001127602-24-000423 · form4.xml · nonDerivative · entry 1

Harrington Robert Arthur · CIK 0001923988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,521

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $84.12, representing the closing stock price of the Issuer's common stock on January 2, 2024.

Read SEC document
December 27, 2023 Filed Dec 27, 2023 21:11 UTC Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $4.44 $0.00
Disclosure

SEC source: 0001127602-23-030485 · form4.xml · derivative · entry 6

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2024-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023.

F2 · derivative.exercise_date: This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015.

Read SEC document
December 27, 2023 Filed Dec 27, 2023 21:11 UTC Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $4.44 $0.00
Disclosure

SEC source: 0001127602-23-030485 · form4.xml · derivative · entry 5

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2024-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023.

F2 · derivative.exercise_date: This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015.

Read SEC document
December 27, 2023 Filed Dec 27, 2023 21:11 UTC SaleCommon Stock 5,000 $73.60 $368,000.00
Disclosure

SEC source: 0001127602-23-030485 · form4.xml · nonDerivative · entry 4

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,653

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023.

Read SEC document
December 27, 2023 Filed Dec 27, 2023 21:11 UTC Exercise / conversionCommon Stock 5,000 $4.44 $22,200.00
Disclosure

SEC source: 0001127602-23-030485 · form4.xml · nonDerivative · entry 3

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,653

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.